Approved for use against rheumatoid arthritis drug Kovid-19

According to the news of the public broadcaster NHK, the rheumatoid arthritis drug “Baricitinib”, a drug produced by Eli Lily from the USA, applied in December 2020, was approved by the ministry for treatment. The government of Japan has also approved the use of “Remdesivir” and “steroid dexamethasone” drugs in the treatment of Kovid-19 so far. Baricitinib “pills will be used once a day and together with” Remdesivir “drug for adult patients who need supplemental…

"Approved for use against rheumatoid arthritis drug Kovid-19"